MF
ACHN

Magnetar Financial’s Achillion Pharmaceuticals ACHN Stock Holding History

Magnetar Financial’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,492,040
Closed -$33.1M – 720
2019
Q4 		$33.1M Buy
+5,492,040
New +$31.8M 0.69% 28

Magnetar Financial's ACHN Position: Q1 2020 in Review

Magnetar Financial sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 5,492,040 shares — an estimated $33.1M sold.

Magnetar Financial first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $33.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Magnetar Financial reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Magnetar Financial sold 5,492,040 Achillion Pharmaceuticals shares in Q1 2020, an estimated $33.1M.
  • Magnetar Financial first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Magnetar Financial's Achillion Pharmaceuticals position peaked at $33.1M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Magnetar Financial's 13F filing for Q1 2020, filed 15 May 2020.